These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7337936)

  • 1. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3363-8. PubMed ID: 7337936
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2621-8. PubMed ID: 7139823
    [No Abstract]   [Full Text] [Related]  

  • 3. Duration of the local anesthetic effect of tetracaine hydrochloride solutions and tetracaine in microspheres.
    Wakiyama N; Juni K; Nakano M
    J Pharmacobiodyn; 1982 Jan; 5(1):13-7. PubMed ID: 7077517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin.
    Juni K; Ogata J; Nakano M; Ichihara T; Mori K; Akagi M
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):313-8. PubMed ID: 4006022
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3719-27. PubMed ID: 7160017
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 May; 44(5):328-30. PubMed ID: 2772012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 Apr; 44(4):276-9. PubMed ID: 2772002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.
    Okada H; Doken Y; Ogawa Y; Toguchi H
    Pharm Res; 1994 Aug; 11(8):1143-7. PubMed ID: 7971715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects.
    Chen PC; Kohane DS; Park YJ; Bartlett RH; Langer R; Yang VC
    J Biomed Mater Res A; 2004 Sep; 70(3):459-66. PubMed ID: 15293320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid].
    Tokuda K; Natsugoe S; Kumanohoso T; Shimada M; Yoshizawa H; Hatate Y; Nakamura K; Yamada K; Nedachi M; Aiko T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1641-3. PubMed ID: 7574782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entrapment of proteins in poly(L-lactide) microspheres using reversed micelle solvent evaporation.
    Hayashi Y; Yoshioka S; Aso Y; Li Wan Po A; Terao T
    Pharm Res; 1994 Feb; 11(2):337-40. PubMed ID: 8165198
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and evaluation in vitro of polycarbonate microspheres containing local anesthetics.
    Kojima T; Nakano M; Juni K; Inoue S; Yoshida Y
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2795-802. PubMed ID: 6499090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of CDDP-PLA microspheres in vitro and in vivo].
    Liu ZK; Wei SL; Lan CQ; Su DY
    Yao Xue Xue Bao; 1993; 28(10):792-7. PubMed ID: 8009994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradation and antitumour effect of adriamycin-containing poly(L-lactic acid) microspheres.
    Ike O; Shimizu Y; Ikada Y; Watanabe S; Natsume T; Wada R; Hyon SH; Hitomi S
    Biomaterials; 1991 Oct; 12(8):757-62. PubMed ID: 1799651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of release rate of bleomycin from polylactic acid microspheres by additives.
    Juni K; Ogata J; Matsui N; Kubota M; Nakano M
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1609-14. PubMed ID: 2412716
    [No Abstract]   [Full Text] [Related]  

  • 19. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives.
    Juni K; Ogata J; Matsui N; Kubota M; Nakano M
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1734-8. PubMed ID: 3862466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.